SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 12, 2003
GUILFORD PHARMACEUTICALS INC.
(Exact name of registrant as specified in its
charter) | | | | |
Delaware | | 0-23736 | | 52-1841960 |
|
(State or other jurisdiction of | | (Commission File | | (I.R.S. Employer |
incorporation or organization) | | Number) | | Identification No.) |
| | | | |
6611 Tributary Street | | | | |
Baltimore, Maryland | | | 21224 |
|
(Address of principal executive offices) | | | (Zip Code) |
Registrant’s telephone number, including area code: (410) 631-6300
(Former name or former address, if changed since last report)
Exhibit Index is on page 4.
INFORMATION TO BE INCLUDED IN THE REPORT
Item 5. Other Events
On June 12, 2003, the Company issued a press release announcing that the Company had entered into an agreement to sell $60 million of convertible subordinated notes ($80 million if the initial purchasers’ option is exercised in full) in a Rule 144A offering. Approximately $5.3 million of the proceeds will be used to repurchase 1.1 million shares of common stock concurrently with the offering. A copy of the Company’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits
99.1 Press Release of Guilford Pharmaceuticals Inc. issued June 12, 2003
- 2 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| GUILFORD PHARMACEUTICALS INC |
|
Dated: June 17, 2003 | By: | /s/ Asher M. Rubin |
| | Asher M. Rubin Vice President, Deputy General Counsel and Secretary |
- 3 -
INDEX TO EXHIBITS
| | | | |
Exhibit | | | | |
Number | | Exhibit Description | | Page |
|
99.1 | | Press Release dated June 12, 2003 | | 5 |
- 4 -